Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2024-12-13 | 2025-02-06 | 245595 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-04-10 | 2020-04-23 | 111851 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2024-02-29 | 2024-07-18 | 220989 |
| TEVA-TOPILENE | 0.05% | OINTMENT | Resolved | 2020-06-25 | 2020-10-01 | 118948 |
| TEVA-TOPILENE | 0.05% | OINTMENT | Actual shortage | 2024-08-30 | 2025-05-08 | 236356 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-06-25 | 2020-09-25 | 118942 |
| TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2021-03-11 | 2023-04-28 | 135552 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2024-02-08 | 2024-07-18 | 218949 |
| TEVA-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-04-11 | 2024-05-23 | 224889 |
| TEVA-TOPIRAMATE | 200MG | TABLET | Resolved | 2023-10-05 | 2024-01-25 | 206398 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-04 | 199345 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-11 | 132649 |
| TEVA-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2025-03-13 | 2025-04-10 | 252584 |
| TEVA-TOPIRAMATE | 200MG | TABLET | Resolved | 2020-10-01 | 2020-10-08 | 125482 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-01-20 | 2022-03-24 | 153147 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2024-04-18 | 2024-06-29 | 225480 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-12-19 | 2025-03-13 | 246098 |
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2023-11-03 | 2023-12-14 | 209119 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-12-01 | 2022-12-15 | 176800 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-07-04 | 2024-11-14 | 232198 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |